Veterinary Medicine Information website

Fiproclear Combo 67 mg / 60.3 mg spot-on solution for small dogs

Authorised
  • Fipronil
  • (S)-Methoprene
Download as PDF

Product identification

Medicine name:
Fiproclear Combo 67 mg / 60.3 mg spot-on solution for small dogs
Active substance:
  • Fipronil
  • (S)-Methoprene
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Fipronil
    67.00
    milligram(s)
    /
    1.00
    Pipette
  • (S)-Methoprene
    60.30
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX65
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • 0.67 ml pipette, moulded from a film composed of 3 layers: a polypropylene/COC/polypropylene, solvent free lacquer laminateand a copolymer of polyethylene/EVOH/polyethylene. The pipettes are sealed within a child resistant 4-ply foil sachetcomposed of LDPE/nylon/aluminium foil/polyester film and presented in an outer box.Boxes of 1 pipette. Each pipette is individually sealed in a foil sachet.
  • 0.67 ml pipette, moulded from a film composed of 3 layers: a polypropylene/COC/polypropylene, solvent free lacquer laminateand a copolymer of polyethylene/EVOH/polyethylene. The pipettes are sealed within a child resistant 4-ply foil sachetcomposed of LDPE/nylon/aluminium foil/polyester film and presented in an outer box.Boxes of 2 pipettes. Each pipette is individually sealed in a foil sachet.
  • 0.67 ml pipette, moulded from a film composed of 3 layers: a polypropylene/COC/polypropylene, solvent free lacquer laminateand a copolymer of polyethylene/EVOH/polyethylene. The pipettes are sealed within a child resistant 4-ply foil sachetcomposed of LDPE/nylon/aluminium foil/polyester film and presented in an outer box.Boxes of 3 pipettes. Each pipette is individually sealed in a foil sachet.
  • 0.67 ml pipette, moulded from a film composed of 3 layers: a polypropylene/COC/polypropylene, solvent free lacquer laminateand a copolymer of polyethylene/EVOH/polyethylene. The pipettes are sealed within a child resistant 4-ply foil sachetcomposed of LDPE/nylon/aluminium foil/polyester film and presented in an outer box.Boxes of 4 pipettes. Each pipette is individually sealed in a foil sachet.
  • 0.67 ml pipette, moulded from a film composed of 3 layers: a polypropylene/COC/polypropylene, solvent free lacquer laminateand a copolymer of polyethylene/EVOH/polyethylene. The pipettes are sealed within a child resistant 4-ply foil sachetcomposed of LDPE/nylon/aluminium foil/polyester film and presented in an outer box.Boxes of 6 pipettes. Each pipette is individually sealed in a foil sachet.
  • 0.67 ml pipette, moulded from a film composed of 3 layers: a polypropylene/COC/polypropylene, solvent free lacquer laminateand a copolymer of polyethylene/EVOH/polyethylene. The pipettes are sealed within a child resistant 4-ply foil sachetcomposed of LDPE/nylon/aluminium foil/polyester film and presented in an outer box.Boxes of 8 pipettes. Each pipette is individually sealed in a foil sachet.
  • 0.67 ml pipette, moulded from a film composed of 3 layers: a polypropylene/COC/polypropylene, solvent free lacquer laminateand a copolymer of polyethylene/EVOH/polyethylene. The pipettes are sealed within a child resistant 4-ply foil sachetcomposed of LDPE/nylon/aluminium foil/polyester film and presented in an outer box.Boxes of 12 pipettes. Each pipette is individually sealed in a foil sachet.
  • 0.67 ml pipette, moulded from a film composed of 3 layers: a polypropylene/COC/polypropylene, solvent free lacquer laminateand a copolymer of polyethylene/EVOH/polyethylene. The pipettes are sealed within a child resistant 4-ply foil sachetcomposed of LDPE/nylon/aluminium foil/polyester film and presented in an outer box.Boxes of 24 pipettes. Each pipette is individually sealed in a foil sachet.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 105009
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0365/002
Concerned member states:
  • Belgium
  • Italy
  • Netherlands
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 24/10/2024
Updated on: 23/10/2024
Download

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Updated on: 13/03/2026
Download